Bretton Capital Management LLC Increases Holdings in UnitedHealth Group Incorporated $UNH

Bretton Capital Management LLC increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 63.7% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 16,700 shares of the healthcare conglomerate’s stock after acquiring an additional 6,500 shares during the period. UnitedHealth Group comprises about 4.7% of Bretton Capital Management LLC’s investment portfolio, making the stock its 11th biggest holding. Bretton Capital Management LLC’s holdings in UnitedHealth Group were worth $5,210,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. LFA Lugano Financial Advisors SA bought a new stake in UnitedHealth Group during the second quarter valued at approximately $25,000. Bayforest Capital Ltd grew its position in shares of UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 48 shares during the period. Sagard Holdings Management Inc. purchased a new position in UnitedHealth Group during the second quarter valued at $29,000. Islay Capital Management LLC purchased a new stake in UnitedHealth Group in the second quarter worth about $31,000. Finally, Clal Insurance Enterprises Holdings Ltd lifted its position in shares of UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after buying an additional 50 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

NYSE:UNH opened at $323.49 on Wednesday. The firm has a market capitalization of $293.03 billion, a price-to-earnings ratio of 16.88, a PEG ratio of 2.11 and a beta of 0.43. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.82. The business has a 50 day simple moving average of $340.93 and a 200-day simple moving average of $316.37. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. During the same period last year, the company earned $7.15 earnings per share. UnitedHealth Group’s revenue was up 12.2% on a year-over-year basis. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be paid a $2.21 dividend. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.7%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 46.14%.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on UNH shares. Mizuho lifted their price target on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday, October 9th. Truist Financial increased their price target on UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research note on Tuesday, September 9th. Deutsche Bank Aktiengesellschaft lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price objective for the company. in a research note on Wednesday, October 29th. TD Cowen boosted their price target on UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a report on Thursday, October 30th. Finally, Sanford C. Bernstein lifted their price objective on shares of UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a research report on Thursday, October 30th. Seventeen equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Hold” and an average price target of $385.54.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.